Kisspeptin-10 and PT-141 place reproductive hormone signalling alongside melanocortin receptor biology. Explore why these distinct pathways attract interest in research on reproductive function and sexual-response signalling.
CURATED INDIVIDUAL ITEMS · TEST / DEMOAT A GLANCE
Inside the stack
Kisspeptin-10
1 × 10 mg single vial · $109.99 CAD each
$109.99 CAD
Kisspeptin-10 is a short kisspeptin fragment used to explore reproductive-hormone signalling. Its interest centres on the kisspeptin receptor and upstream regulation of the reproductive axis.
Reproductive-axis signalling — The kisspeptin system connects upstream signals with GnRH-related endocrine biology.
Short-fragment identity — KP-10 is a ten-amino-acid fragment, distinct from kisspeptin-54.
Hormone physiology — Reviewed acute KP-10 experiments in healthy men measured luteinizing hormone and its pulse pattern; this is distinct from kisspeptin-54 evidence.
PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied in sexual-response signalling. Its receptor-focused identity offers a neural perspective distinct from reproductive-hormone peptides.
Melanocortin receptors — Receptor activity is the starting point for understanding its neural signalling role.
Sexual-response research — Reviewed clinical findings describe a specific manufactured formulation and study population.
Distinct pathway — Its melanocortin identity differs from kisspeptin’s reproductive-axis pathway.
Kisspeptin-10 is the short fragment used to investigate the kisspeptin receptor and upstream reproductive-hormone signals. PT-141 engages melanocortin receptors. Findings for kisspeptin-54 must remain separate from this 10-amino-acid identity.
Explore the evidence & study context
Kisspeptin-10
Human physiology
Kisspeptin-10 produced a rapid rise in measured luteinizing hormone in the 2011 experiments.
An acute hormone response is not a demonstrated fertility or sexual-performance benefit.
The stack contains separately labelled vials, not one combined mixture. A constituent such as GLOW or CJC/ipamorelin is itself a premixed blend, as named in the catalogue.
How is the price calculated?
The selected total is the sum of the current retail price of each constituent vial, multiplied by its displayed quantity. Two vials means two single-vial prices, not a bulk tier. No additional stack discount is applied.
Does adding this change a paid order?
No. The items enter your current demo bag together. Existing bag lines increase by their stated quantities; paid test orders remain unchanged. Checkout is simulated.
What handling information is available?
Format, strength and quantity are shown for each item. Storage, identity, purity and handling require verified batch-specific documentation. This collection supplies no dosing or cycle schedule.
Can component evidence prove the collection works?
No. Study findings retain their individual experimental context. A shared research theme does not establish the effects or safety of a combination.
Selank and Semax bring two complementary research questions into view: GABA-related signalling and neurotrophic pathways involved in learning and memory. A focused starting point for exploring stress-response and cognitive neuroscience.
Explore growth-hormone signalling and cellular adaptation with two vials each of CJC-1295 with DAC, ipamorelin and MOTS-c. This collection brings growth-axis and mitochondrial research into one clearly specified selection.